Update on US FDA Inspection at St. Louis, USA November 10, 2022

Alkem Laboratories launches Cetuxa. World’s first biosimilar of Cetuximab for Head and Neck Cancer. May 29, 2023 Source link

Q4FY23 Results, Press Release and Investor Presentation May 19, 2023 Source link

Closure of US FDA Inspection at Ankleshwar April 7, 2023 Source link

Closure of US FDA Inspection at Indore February 23, 2023 Source link

Q3FY23 Results, Press Release and Investor Presentation February 10, 2023 Source link

Q2FY23 Results, Press Release and Investor Presentation November 11, 2022 Source link